Portfolio Lab

Privia Health Group, Inc.

  • Stock
  • Ticker PRVA
  • Nasdaq

Health care · Health care services · USA

$25.05 +1.46%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Privia Health Group, Inc. since 04/2021, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

PRVAGlobal equities (VT)

$10,000 grew to $9,747. Global equities (VT): $14,653.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −67.3% in 05/2024, measured from the peak in 06/2021. The old peak has not been reached again yet.

1-year return
+11.1%
5-year return p.a.
−2.8%
Return p.a. since 04/2021
+1.5%
Volatility p.a.
45.9%
Largest decline
−67.3%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue461480521580541604633657
Operating income5.25.23.314117.41221
EBITDA7.17.15.91714111524
Net income4.44.22.76.99.23.19.013
Earnings per share0.030.030.020.050.070.020.070.10
Balance sheet
Total assets1,1361,1841,2731,3511,3691,4181,4891,564
Liabilities452474539588578612651691
Equity635659683709737753782816
Cash491469390441480420412446
Cash flow
Operating cash flow75-248.052128-491.129
Free cash flow75-248.052128-491.129

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2025 at +21.3%, weakest 2024 at −15.1%. 2 of 4 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026$0.10
6 Aug 2026$0.07
7 May 2026$0.02
27 Feb 2026$0.07
6 Nov 2025$0.05
7 Aug 2025$0.02
8 May 2025$0.03
27 Feb 2025$0.03
7 Nov 2024$0.03
8 Aug 2024$0.03
9 May 2024$0.02
27 Feb 2024$0.03

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€2.9bn
Market cap in trading currency
$3.20bn
Enterprise value
$2.75bn
P/E
96.3
P/S
1.31
P/B
3.92
EV/Sales
1.13
EV/EBITDA
43.2
Earnings yield
1.0%
FCF yield
3.4%

Results (last four quarters)

Revenue
$2.43bn
Gross profit
–
EBITDA
$63.8m
Net income
$34.8m
Earnings per share
$0.26
Revenue per share
$19.05
Revenue growth
+13.2%
Earnings growth
+96.6%

Profitability

Gross margin
–
Operating margin
2.1%
Net margin
1.4%
Return on equity
4.6%
Return on assets
2.2%

Balance sheet and cash flow

Cash
$446m
Cash per share
$3.49
Financial debt
–
Debt/equity %
–
Current ratio
1.63
Book value per share
$6.38
Operating cash flow
$108m
Free cash flow
$108m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
128m
Volume
1.93m
Avg. volume 3 months
1.27m
Relative volume
1.5

Price and technicals

Price
$25.05
1 day
+1.5%
52-week high
$28.10
52-week low
$19.10
Distance to 52-week high
−10.9%
Distance to 52-week low
+31.2%
Distance to 50-day line
+14.7%
Distance to 200-day line
+10.2%
RSI (14)
67
Volatility 1M
37.3%

Performance

1 week
+2.0%
1 month
+9.5%
3 months
+19.2%
6 months
+9.9%
YTD
+5.7%
1 year
+11.2%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has PRVA performed since 04/2021?

$10,000 grew to $10,891 by 20 Nov 2026, which is +1.5% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is PRVA?

Volatility was 45.9% per year, measured on monthly returns. The largest decline from a peak was −67.3%, with the low in 05/2024.

How does PRVA compare with a broad equity ETF?

Over the same period Global equities (VT) returned +8.2% per year at 14.9% volatility, PRVA returned +1.5% at 45.9%. The correlation of monthly returns was 0.22; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Privia Health Group, Inc. (PRVA): Return and risk